AzTrials
AzTrials

Colonic PolypsNCT04749277

Artificial Intelligence in the Characterization of Colorectal Polyps

An observational study of Colonic Polyps, run by Unidade Local de Saúde de Coimbra, EPE at 1 site in Portugal.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Current guidelines recommend resection and histopathological analyses of all colorectal polyps. Real-time optical diagnosis can obviate non-neoplastic polyp resection ("diagnose-and-leave-behind") and histopathological analyses of diminutive polyps ("predict-resect-and-discard") reducing healthcare and cost burden. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Colonic Polyps
What is being tested?
CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)
How many people
197 participants
Where
1 sitePortugal
Study dates
1 Jan 2021to 30 Apr 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.

Who may be able to join

  • Age ≥18 years;
  • The presence of at least one polyp in an elective colonoscopy.

Who cannot join

  • Poor bowel preparation (Boston Bowel Preparation Score <6 at the total score or <2 at one of colorectal segment);
  • No recovery of excised polyps for histopathological analysis;
  • The presence of polyps not amenable to endoscopic excision or with contraindication for their excision at the time of colonoscopy;
  • The absence of explicit indication for colonoscopy.

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Centro Hospitalar e Universitário de Coimbra

    Coimbra, 3000-075

Other trials in Portugal

About this study

Official title: Artificial Intelligence in the Characterization of Small and Diminutive Colorectal Polyps: A Prospective Study in a Clinical Setting Using CAD EYE®

Current guidelines recommend resection and histopathological analyses of all colorectal polyps. Real-time optical diagnosis can obviate non-neoplastic polyp resection ("diagnose-and-leave-behind") and histopathological analyses of diminutive polyps ("predict-resect-and-discard") reducing healthcare and cost burden. The investigators aimed to evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® (Fujifilm,Germany) in real-time optical characterization of colorectal polyps compared to endoscopic diagnosis with histopathology as the gold-standard. For this purpose, a single-centre prospective study of diminutive/small colorectal polyps is ongoing.

Read the detailed description

Introduction Worldwide, colorectal cancer (CRC) is the 4th most frequent cancer and the 3rd cause of cancer-related death. In Portugal, CRC is the 3rd most common cause and the 2nd leading cause of cancer-related mortality. In colorectal carcinogenesis, colorectal polyps (adenomatous or serrated polyps) are considered premalignant lesions. The detection of colorectal polyps and subsequent resection is effective in reducing CRC incidence and mortality and the risk of interval CRC, and is the crucial aspect of CRC prevention. Considering the detection of colorectal polyps, there is a wide variation among endoscopists in terms of skills for the detection of adenomas, the major premalignant lesions of CRC, translated into the detection rate of adenomas (ADR). ADR is considered a marker of careful inspection of colorectal mucosa, translating quality in colonoscopy, which is inversely associated with the risk of interval CRC or cancer-related death. In the context of screening colonoscopy, the minimum ADR is 25% to reduce the risk of interval CRC and death, being predictably higher if a positive fecal occult blood test is found, although the exact value still remains to be elucidated. The detection rate of serrated polyps has been strongly correlated with ADR.

About 50% of small polyps are non-adenomatous and these polyps have no malignancy potential, especially for small polyps, whose cancer risk is extremely low (0-0.6%). The resection of these non-adenomatous polyps may increase medical costs and risks related to post-polypectomy complications (bleeding, perforation).

Real time optical diagnosis by artificial intelligence can improve the cost-benefit and efficiency of colonoscopy as an auxiliary tool in the decision making of which polyps should be resected and which polyps should be recovered for histological characterization. However, its practical application implies a negative predictive value ≥ 90% in optical diagnosis in order to don´t have implications in terms of interval CRC and medico-legal issues.

CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany) is a fully-automated computer program, which allows the detection of colorectal polyps as well as their histological classification using the artificial intelligence technology using deep learning, so-called REilI. When applied in a high-quality colonoscopy, it seems to improve the detection rate of polyps and the ADR in real time, during colonoscopy course. In fact, the detection of difficult lesions remains one of the major challenges in the endoscopy field in last years, particularly for flat lesions, multiple polyps and polyps located at the image periphery. The detection of colorectal polyps is shown by 3 simultaneous identifiers, 2 visual and 1 auditory. The visual identifiers correspond to a detection box in the area of suspected polyps and a semicircle at the periphery of the image, corresponding to the quadrant where the suspect polyps are located. The auditory stimulus corresponds to a volume adjustable sound signal emitted when a suspect polyps is detected. Regarding the optical characterization of histopathology, colo-rectal polyps are classified into 2 types, hyperplastic (green colour), which include hyperplastic and serrated polyps, and neoplastic (yellow colour), for adenomas and adenocarcinomas. In addition, it allows to perform this characterization in 3 confidence levels and the mapping of the position of the suspected area.

This system allows the storage of videos related to both detection and characterization of colorectal polyps, one of the recognized quality tools in colonoscopy.

The detection mode of colorectal polyps is performed in white light imaging (WLI) or Linked Colour Imaging (LCI), while the optical characterization is performed in Blue Light Imaging (BLI) mode, without the need to fix or zoom the image. This tool is user-friendly, simple, intuitive and does not interfere with colonoscopy images.

Objectives

Primary objectives

  • To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy;
  • To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis.

Secondary objectives

  • To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of dimension (≤5, 6-9mm and ≥10mm), location and histological type (hyperplastic, serrated sessile lesion, adenoma, adenocarcinoma);
  • To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps according to the experience of the endoscopist.

Population and methodology

Type of study Prospective observational cohort study

Type of sample The total number of consecutive patients who underwent elective colonoscopy with high quality of bowel preparation (at least two points per segment and at least of six points at the total score of Boston Bowel Preparation), performed at the Gastroenterology Department of the Centro Hospitalar e Universitário de Coimbra, E.P.E., Coimbra, Portugal, with at least one identified colorectal polyp, regardless the indication for its performance.

Study design All colonoscopies will be performed by the endoscopist (trainee and experienced endoscopist) using CAD EYE® in detection mode (WLI or LCI), during colonoscopy retrieval. When a suspected polyp is identified by the endoscopist, optical characterization is performed by the endoscopist in WLI and BLI modes, in a first phase and by the CAD EYE® with BLI, in a second phase.

Methods plan Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)

Phase 2. CAD EYE® system applied during colonoscopy retrieval:

2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization

Detailed explanation of Methods phases Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI) Virtual chromoendoscopy training should be performed online through the BASIC e-learning platform (bli.eu/category/e-learning/). This training should be carried out by all participants enrolled in the project (trainees and experienced endoscopists) before its practical application, which will allow skills acquisition on the characterization of virtual chromoendoscopy of colorectal polyps using BLI. Additionally, a brief review of the Kudo classification of pit pattern of colorectal polyps should be carried out.

Phase 2. Evaluation of colorectal polyps in real-time - Optical characterization of colorectal polyps The first approach on optical characterization of an identified polyp consists in the evaluation of the polyp, first in WLI mode and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, and the evaluation of both should be recorded on a separate record sheet by the endoscopist who is not performing the examination. The two endoscopists should preferably (but not necessarily) be an experienced endoscopist and a trainee from the last few years, and the presence of at least one experienced endoscopist is mandatory. The independent evaluation is guaranteed by a phased and recorded approach: 1st step - The 1st endoscopist (endoscopist performing colonoscopy) request the polyp evaluation and written record by the 2nd endoscopist (the one who is not performing the colonoscopy) - blinded evaluation because the 1st endoscopist doesn't verbalize his evaluation); 2nd moment - when the 2nd endoscopist signals that he has completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include the histopathological type of polyp (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low). Kudo classification of pit pattern can also be recorded (optional).

Afterwards, optical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet.

The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done.

Phase 3. Histopathological evaluation (by pathologist with gastrointestinal expertise) After detection and optical characterization of identified colorectal polyps, their resection should be performed by the most appropriate technique according to the size and type of polyp (cold forceps polypectomy if dimensions <3mm), cold snare polypectomy if dimension between 3-10mm and diathermic snare polypectomy/endoscopic mucosal resection if lesions >10mm) and recovery of colorectal polyp for anatomopathological characterization. Each colorectal polyp should be recovered to a separate vial. Unrecovered polyps will not be counted for comparative evaluation of optical characterization.

Statistical analysis The diagnostic performance of CAD EYE® will be evaluated by comparison with the gold standard (histological characterization in the optical characterization phase), in terms of diagnostic accuracy, sensitivity, specificity, positive predictive value and negative predictive value. Sub-analysis can be performed regarding the size, location and histological type of polyp, as well as the expertise of the endoscopist.

Sample size calculation For an alpha risk of 0.05 and beta risk of 0.2 for a bilateral test, it will be necessary to include 197 colorectal polyps assuming the initial pre-intervention diagnostic ratio is 0.7 and the final after-intervention ratio is 0.82.

Expected Results It is expected that the new CAD EYE® system will have a diagnostic accuracy in the optical characterization of colorectal polyps around 78.4%, comparable to experienced endoscopists (78.4% vs 79.6%) and superior to less experienced endoscopists (70.7% vs 79.6%).(14) Thus, the new CAD EYE® system will allow optical characterization with high accuracy impacting as a decision making tool for the endoscopist in strategies based on optical diagnosis such as "diagnosis and leave behind" for diminutive polyps from sigmoid colon and rectum with high degree of confidence in hyperplastic histology and "predict, resect and discard" for diminutive polyps.

Conditions
Colonic Polyps
Being tested
CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)
Keywords
Artificial Intelligence, Colonoscopy, Colonic Polyps
Medical subject headings
Colonic Polyps

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)Other

    Methods plan

    Phase 1. Brief virtual chromoendoscopy training on the characterization of colorectal polyps (WLI, LCI and BLI)

    Phase 2. CAD EYE® system applied during colonoscopy retrieval:

    2.1. CAD EYE® system OFF: Virtual chromoendoscopy (BLI) - independently characterization of a suspected polyp in WLI and BLI by the first endoscopist and by the second endoscopist (iconographic record) 2.2. CAD EYE® system ON: Characterization mode (BLI): Characterization of a suspected polyp by CAD EYE® and respectively level of characterization (1 to 3) (iconographic record) Phase 3. Histopathological evaluation (pathologist with gastrointestinal expertise): Resection and recovery of a suspected polyp for anatomopathological characterization

Study groups in NCT04749277
Study groupRoleWhat they receive
Endoscopist characterization on WLI and BLI modesOptical characterization of an identified polyp, first in WLI and then in BLI mode, with CAD EYE® OFF. This evaluation should be systematically performed by two independent endoscopists in the exam room, preferably (but not necessarily) an experienced endoscopist and a trainee. The presence of at least one experienced endoscopist is mandatory. An independent evaluation is guaranteed. First step - The 1st endoscopist (who performing colonoscopy) request the polyp evaluation and record written by the 2nd endoscopist (who not performing the colonoscopy) - blinded evaluation since 1st endoscopist doesn't verbalize his evaluation); 2nd step - when the 2nd endoscopist signals that he completed his record, the 1st endoscopist verbally explicit his classification, which is recorded by the 2nd endoscopist. This evaluation should include polyp histological type (hyperplastic, adenoma, sessile serrated lesion or other type) and the level of confidence of the evaluation performed (high or low).
CAD EYE® characterization on BLI modeOptical characterization mode of CAD EYE® (CAD EYE® ON) in BLI mode should be activated for the evaluation of CAD EYE® optical characterization, in hyperplastic or neoplastic polyps, as well as the level of characterization (graduated from 1 to 3). The evaluation of the CAD EYE® should also be recorded by the endoscopist in the exam room who is not performing the colonoscopy, on its own record sheet. The iconographic record of evaluated polyps in WLI and BLI modes and the evaluation video using CAD EYE® in BLI characterization mode should be done.
Receives: Other: CAD EYE® (Fujifilm, Europe, Gesellschaft mit beschränkter Haftung, Dusseldorf, Germany)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Real-time optical characterization of colorectal polyps (CAD EYE® versus Histopathology)

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps by comparison with histopathological analysis

    Measured: 2 months

  2. Real-time optical characterization of colorectal polyps (Endoscopist versus Histopathology)

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps compared to digital chromoendoscopy by endoscopists

    Measured: 2 months

Secondary outcomes (4)
  1. Real-time optical characterization of colorectal polyps according to polyps size

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of dimension (≤5, 6-9mm and ≥10mm)

    Measured: 2 months

  2. Real-time optical characterization of colorectal polyps according to polyps location

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of location (right and left colon)

    Measured: 2 months

  3. Real-time optical characterization of colorectal polyps according to polyps histological type

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps in terms of histological type (hyperplastic, serrated sessile lesion, adenoma, adenocarcinoma)

    Measured: 2 months

  4. Real-time optical characterization of colorectal polyps according to endoscopist experience

    To evaluate the diagnostic accuracy of computer-aided diagnosis using CAD EYE® system in real-time optical characterization of colorectal polyps according to the experience of the endoscopist (trainee and experienced endoscopists)

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Feb 2021
  2. Study start1 Jan 2021
  3. Primary completion28 Feb 2021
  4. Study completion30 Apr 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
197 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04749277
Sponsor's protocol ID
CHUCoimbra
Status last verified
Jul 2021
First submitted
31 Jan 2021
Last updated
28 Jul 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol. 2016 Mar;111(3):355-65. doi: 10.1038/ajg.2015.418. Epub 2016 Jan 12.

    PubMed 26753884
  • Bretthauer M, Kaminski MF, Loberg M, Zauber AG, Regula J, Kuipers EJ, Hernan MA, McFadden E, Sunde A, Kalager M, Dekker E, Lansdorp-Vogelaar I, Garborg K, Rupinski M, Spaander MC, Bugajski M, Hoie O, Stefansson T, Hoff G, Adami HO; Nordic-European Initiative on Colorectal Cancer (NordICC) Study Group. Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial. JAMA Intern Med. 2016 Jul 1;176(7):894-902. doi: 10.1001/jamainternmed.2016.0960.

    PubMed 27214731
  • Zorzi M, Senore C, Da Re F, Barca A, Bonelli LA, Cannizzaro R, de Pretis G, Di Furia L, Di Giulio E, Mantellini P, Naldoni C, Sassatelli R, Rex DK, Zappa M, Hassan C; Equipe Working Group. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy). Gut. 2017 Jul;66(7):1233-1240. doi: 10.1136/gutjnl-2015-310587. Epub 2016 Feb 19.

    PubMed 26896459
  • Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, Didkowska J, Zwierko M, Rupinski M, Nowacki MP, Butruk E. Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 2010 May 13;362(19):1795-803. doi: 10.1056/NEJMoa0907667.

    PubMed 20463339
  • Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 3;370(14):1298-306. doi: 10.1056/NEJMoa1309086.

    PubMed 24693890
  • van Rijn JC, Reitsma JB, Stoker J, Bossuyt PM, van Deventer SJ, Dekker E. Polyp miss rate determined by tandem colonoscopy: a systematic review. Am J Gastroenterol. 2006 Feb;101(2):343-50. doi: 10.1111/j.1572-0241.2006.00390.x.

    PubMed 16454841
  • Kaminski MF, Thomas-Gibson S, Bugajski M, Bretthauer M, Rees CJ, Dekker E, Hoff G, Jover R, Suchanek S, Ferlitsch M, Anderson J, Roesch T, Hultcranz R, Racz I, Kuipers EJ, Garborg K, East JE, Rupinski M, Seip B, Bennett C, Senore C, Minozzi S, Bisschops R, Domagk D, Valori R, Spada C, Hassan C, Dinis-Ribeiro M, Rutter MD. Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative. United European Gastroenterol J. 2017 Apr;5(3):309-334. doi: 10.1177/2050640617700014. Epub 2017 Mar 16.

    PubMed 28507745
  • Ferlitsch M, Moss A, Hassan C, Bhandari P, Dumonceau JM, Paspatis G, Jover R, Langner C, Bronzwaer M, Nalankilli K, Fockens P, Hazzan R, Gralnek IM, Gschwantler M, Waldmann E, Jeschek P, Penz D, Heresbach D, Moons L, Lemmers A, Paraskeva K, Pohl J, Ponchon T, Regula J, Repici A, Rutter MD, Burgess NG, Bourke MJ. Colorectal polypectomy and endoscopic mucosal resection (EMR): European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline. Endoscopy. 2017 Mar;49(3):270-297. doi: 10.1055/s-0043-102569. Epub 2017 Feb 17.

    PubMed 28212588
  • Min M, Su S, He W, Bi Y, Ma Z, Liu Y. Computer-aided diagnosis of colorectal polyps using linked color imaging colonoscopy to predict histology. Sci Rep. 2019 Feb 27;9(1):2881. doi: 10.1038/s41598-019-39416-7.

    PubMed 30814661
  • Brenner H, Altenhofen L, Kretschmann J, Rosch T, Pox C, Stock C, Hoffmeister M. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program. Gastroenterology. 2015 Aug;149(2):356-66.e1. doi: 10.1053/j.gastro.2015.04.012. Epub 2015 Apr 22.

    PubMed 25911510
  • van der Zander QEW, Schreuder RM, Fonolla R, Scheeve T, van der Sommen F, Winkens B, Aepli P, Hayee B, Pischel AB, Stefanovic M, Subramaniam S, Bhandari P, de With PHN, Masclee AAM, Schoon EJ. Optical diagnosis of colorectal polyp images using a newly developed computer-aided diagnosis system (CADx) compared with intuitive optical diagnosis. Endoscopy. 2021 Dec;53(12):1219-1226. doi: 10.1055/a-1343-1597. Epub 2021 Mar 10.

    PubMed 33368056
  • Weigt J, Repici A, Antonelli G, Afifi A, Kliegis L, Correale L, Hassan C, Neumann H. Performance of a new integrated computer-assisted system (CADe/CADx) for detection and characterization of colorectal neoplasia. Endoscopy. 2022 Feb;54(2):180-184. doi: 10.1055/a-1372-0419. Epub 2021 Apr 20.

    PubMed 33494106
  • Lui TKL, Guo CG, Leung WK. Accuracy of artificial intelligence on histology prediction and detection of colorectal polyps: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Jul;92(1):11-22.e6. doi: 10.1016/j.gie.2020.02.033. Epub 2020 Feb 29.

    PubMed 32119938
  • van de Wetering AJP, Meulen LWT, Bogie RMM, van der Zander QEW, Reumkens A, Winkens B, Cheng HR, Straathof JA, Dekker E, Keulen E, Bakker CM, Hoge C, de Ridder R, Masclee AAM, Sanduleanu-Dascalescu S. Optical diagnosis of diminutive polyps in the Dutch Bowel Cancer Screening Program: Are we ready to start? Endosc Int Open. 2020 Mar;8(3):E257-E265. doi: 10.1055/a-1072-4853. Epub 2020 Feb 21.

    PubMed 32118099
  • Song EM, Park B, Ha CA, Hwang SW, Park SH, Yang DH, Ye BD, Myung SJ, Yang SK, Kim N, Byeon JS. Endoscopic diagnosis and treatment planning for colorectal polyps using a deep-learning model. Sci Rep. 2020 Jan 8;10(1):30. doi: 10.1038/s41598-019-56697-0.

    PubMed 31913337

Questions about this trial

What is this clinical trial studying?

An observational study of Colonic Polyps, run by Unidade Local de Saúde de Coimbra, EPE at 1 site in Portugal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Portugal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Real-time optical characterization of colorectal polyps (CAD EYE® versus Histopathology) (time frame: 2 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04749277, which also lists 19 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in